Clairity
Founded in 2020 and headquartered in Boston, Massachusetts, Clairity, Inc. is transforming healthcare risk assessment through the power of artificial intelligence and deep learning. Founded by Dr. Connie Lehman, backed by Santé Ventures and ACE Global Equity, Clairity's technology can uncover subtle patterns in routine images that are invisible to the human eye, enhancing risk prediction to empower clinicians and their patients with actionable, personalized insights. Clairity’s mission is to shift the standard of care from late-stage treatment to proactive prevention.
Content by Clairity
|3 min read
AI in Breast Cancer Risk Prediction: Clairity to Showcase New Research at RSNA 2025
Clairity’s first FDA authorized AI platform for breast cancer prediction demonstrates consistent accuracy, real-world impact, and potential to transform global breast cancer screening
|2 min read
FDA Grants De Novo Authorization for New Device for Future 5-Year Breast Cancer Risk Prediction, Based on an Image Alone
A milestone in equitable health care, with potentially life-saving insights from a screening mammogram alonePage 1 of 1
